Goods specified in Supplementary Note 3 to this Chapter
Carboxylic acid derivatives under Chapter 29 supplementary note
HSN 2918 99 30 covers goods specified in Supplementary Note 3 to Chapter 29 and is subject to mandatory registration or import permit requirements under the Central Drugs Standard Control Organisation (CDSCO) and the Central Insecticides Board and Registration Committee (CIB&RC) depending on end-use, with Ministry of Health and Family Welfare (MOHFW) conditions applying to notified medical devices. Import is Free under the ITC (HS) policy administered by the Directorate General of Foreign Trade (DGFT) subject to policy condition 7 of Chapter 29, with additional overlays for narcotic drugs and psychotropic substances, ozone-depleting substances, and hazardous waste governed by the Narcotic Drugs and Psychotropic Substances (NDPS) regime and Ministry of Environment, Forest and Climate Change (MEFCC) rules.
- Registration certificate or import permit from CIB&RC
- CDSCO registration from CDSCO
- Chapter 29 qualifiers from CBIC
Procedural directions for customs clearance are issued by: Directorate General of Foreign Trade, Central Board of Indirect Taxes and Customs.
- 1Determine the end-use category of the goods under Supplementary Note 3 to Chapter 29 before filing the bill of entry. Where the substance is a listed insecticide under Section 3(e) of the Schedule to the Insecticides Act, 1968, obtain mandatory registration from CIB&RC; where imported for a non-insecticidal purpose, obtain an import permit from the Registration Committee, which spells out conditions including approved source of import. Import from any source not specified on the registration certificate or permit constitutes a violation under the Insecticides Act, 1968.Section 9 of the Insecticides Act, 1968 · Rule 45 of the Insecticides Rules, 1971 · CBIC Circulars 35/11 dated 09-08-2011 and 7/14 dated 07-03-2014
- 2If the goods fall within the list of medical devices notified in G.S.R. 102(E) dated 11-02-2020 issued by MOHFW, comply with all conditions including CDSCO registration before import. Mandatory Chapter 29 additional qualifiers must be declared in the import declaration per CBIC Circular 23/2023-Cus dated 30-09-2023, paragraphs 4.1 and 4.2, with effect from 15-10-2023.G.S.R. 102(E) dated 11-02-2020 (MOHFW) · CBIC Circular 23/2023-Cus dated 30-09-2023
- 3For imports of narcotic drugs or psychotropic substances covered under Chapter 29, comply with policy conditions 2 and 3 of Chapter 29 as applicable. For hazardous substances exceeding specified quantities, take out a public liability insurance policy under the Public Liability Insurance Act, 1991 per S.O. 227(E) dated 24-03-1992 issued by MEFCC; for ozone-depleting substances, comply with policy conditions 1, 4 and 5 of Chapter 29 and the Ozone Depleting Substances (Regulation and Control) Rules, 2000; for waste, comply with Rules 12 and 13 of the Hazardous Waste (Management and Transboundary Movement) Rules, 2016 and paragraph 8(b) of the General Notes.DGFT Notification 44/2025-26 dated 15-10-2025 · S.O. 227(E) dated 24-03-1992 · Ozone Depleting Substances (Regulation and Control) Rules, 2000 · Hazardous Waste (Management and Transboundary Movement) Rules, 2016
The single most common error on this tariff line is filing the bill of entry without first resolving which of the several parallel regimes applies to the specific substance: a chemical that is a listed insecticide requires CIB&RC registration, while the same molecule imported for a pharmaceutical or medical-device purpose requires CDSCO registration under the conditions of G.S.R. 102(E). End-use misclassification at filing triggers detention pending PGA clarification and, where the substance is scheduled under NDPS, criminal liability attaches independent of any civil customs breach. Confirm the applicable regime against Supplementary Note 3 to Chapter 29 and the Finance Bill 2025 amendments before the purchase order is placed.